Skip to main content
. 2018 Oct 1;53(6):2433–2444. doi: 10.3892/ijo.2018.4580

Figure 4.

Figure 4

miR-103 promotes the EMT of HCC cells. (A) Western blot analysis of E-cadherin and vimentin expression following the overexpression of miR-103 in HCC cells. GAPDH was used as an internal control (*P<0.05). (B) Immunohistochemistry of E-cadherin and vimentin comparing tissues with a high miR-103 level and those with a low miR-103 level (*P<0.05; magnification, ×400). (C) Left panel, miR-103 expression negatively correlates with E-cadherin expression (Spearman's r=−0.864; see Table II); right panel, miR-103 expression positively correlates with vimentin expression (Spearman's r=0.712; see Table II). EMT, epithelial-mesenchymal transition; HCC, hepatocellular carcinoma; NC, negative control.